Skip to main content
CDC Website

TB

TB

False-Positive Cultures for Mycobaterium Tuberculosis

This information sheet contends that new rapid diagnostic laboratory techniques appear to have increased the possiblity of laboratory cross contamination and explains how to avoid diagnostic errors based on false-positive cultures.

Alerta de viaje internacional: Tuberculosis[International Travel Information: Tuberculosis]

General information on traveling internationally for those at risk or have TB in Spanish.

Refusal of Care Form

This contract form is for persons who refuse TB care, given they have been informed about LTBI and TB disease.

Instruções Para Coleta De Escarro Para TB[Instructions for Collecting Sputum for TB]

This pamphlet explains how to collect a sputum specimen at home for laboratory analysis.

What You Need to Know About Tuberculosis

The purpose of this flipbook is to assist healthcare workers in providing patient education around TB testing, TB infection and TB disease. Panels for patients include simple text and images to reinforce key messages and corresponding panels for providers include easy to deliver script and teaching points.

Tuberculosis: New Faces of an Old Disease

This Special Report from Medecins Sans Frontieres/Doctors Without Borders highlights the challenges, such as TB/HIV coinfection and drug resistance, faced in the fight against TB. The report also provides real-life examples of people living with TB.

Directly Observed Therapy (DOT) Program

This fact sheet explains the facts about DOT.

What Does a Negative TB Skin Test Mean?

This fact sheet discusses the meaning of a negative TB skin test and states that persons with HIV/AIDS may be at risk for false negative results.

World TB Day--March 24, 2001. Morbidity and Mortality Weekly Report. 50(11):201, March 24, 2001

This announcement gives a brief overview of World TB Day, which recognizes the collaborative efforts of all countries involved in eliminating TB.

MMWR: Fatal and Severe Hepatitis Associated with Rifampin and Pyrazinamide for the Treatment of Latent Tuberculosis Infection--New York and Georgia, 2000

This report discusses two cases of latent TB infection in which patients developed severe or fatal hepatitis associated with rifampin-pyrazinamide (RIF-PZA) treatment.